In vitro cytochrome P450 inhibition potential of methylenedioxy-derived designer drugs studied with a two-cocktail approach

Codeine Intoxication Associated with Ultrarapid CYP2D6 Metabolism

Yvan Gasche, Youssef Daali, Marc Fathi et al. · New England Journal of Medicine · 2004 · 700 citations · Full text

Medicine, Pharmacology, Toxicology +17

Fluvoxamine is a potent inhibitor of cytochrome P4501A2

Kim Brøsen, Erik Skjelbo, Birgitte Buur Rasmussen et al. · Biochemical Pharmacology · 1993 · 372 citations

Medicine, Pharmacokinetics, Pharmacology +13

Pharmacokinetic drug-drug interaction and their implication in clinical management.

Caterina Palleria, Antonello Di Paolo, Chiara Giofrè et al. · PubMed · 2013 · 337 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development.

Paweł Baranczewski, Andrzej Stańczak, Kathrin Sundberg et al. · PubMed · 2007 · 290 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Apparent Mechanism-based Inhibition of Human CYP2D6 in Vitro by Paroxetine: Comparison with Fluoxetine and Quinidine

Kirk Bertelsen, Karthik Venkatakrishnan, Lisa L. von Moltke et al. · Drug Metabolism and Disposition · 2003 · 276 citations

Medicine, Pharmacokinetics, Pharmacology +17